Dohm Ammoren, McTyre Emory R, Chan Michael D, Fan Claire, Isom Scott, Bourland J Daniel, Mott Ryan T, Cramer Christina K, Tatter Stephen B, Laxton Adrian W
Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
J Clin Neurosci. 2017 Dec;46:90-98. doi: 10.1016/j.jocn.2017.08.023. Epub 2017 Sep 13.
We report a single institution series of surgery followed by either early adjuvant or late radiotherapy for atypical meningiomas (AM). AM patients, by WHO 2007 definition, underwent subtotal resection (STR) or gross total resection (GTR). Sixty-three of a total 115 patients then received fractionated or stereotactic radiation treatment, early adjuvant radiotherapy (≤4months after surgery) or late radiotherapy (at the time of recurrence). Kaplan Meier method was used for survival analysis with competing risk analysis used to assess local failure. Overall survival (OS) at 1, 2, and 5years for all patients was 87%, 85%, 66%, respectively. Progression free survival (PFS) at 1, 2, and 5years for all patients was 65%, 30%, and 18%, respectively. OS at 1, 2, and 5years was 75%, 72%, 55% for surgery alone, and 97%, 95%, 75% for surgery+radiotherapy (log-rank p-value=0.0026). PFS at 1, 2, and 5years for patients undergoing surgery without early adjuvant radiotherapy was 64%, 49%, and 27% versus 81%, 73%, and 59% for surgery+early adjuvant radiotherapy (log-rank p-value=0.0026). The cumulative incidence of local failure at 1, 2, and 5years for patients undergoing surgery without early External Beam Radiation Therapy (EBRT) was 18.7%, 35.0%, and 52.9%, respectively, versus 4.2%, 13.3%, and 20.0% for surgery and early EBRT (p-value=0.02). Adjuvant radiotherapy improves OS in patients with AM. Early adjuvant radiotherapy improves PFS, likely due to the improvement in local control seen with early adjuvant EBRT.
我们报告了一个单一机构的系列研究,该研究对非典型脑膜瘤(AM)患者进行手术,术后接受早期辅助放疗或晚期放疗。根据世界卫生组织2007年的定义,AM患者接受了次全切除(STR)或全切除(GTR)。在总共115例患者中,有63例随后接受了分次或立体定向放射治疗,即早期辅助放疗(手术后≤4个月)或晚期放疗(复发时)。采用Kaplan-Meier方法进行生存分析,并使用竞争风险分析来评估局部失败情况。所有患者1年、2年和5年的总生存率(OS)分别为87%、85%、66%。所有患者1年、2年和5年的无进展生存率(PFS)分别为65%、30%和18%。单纯手术患者1年、2年和5年的OS分别为75%、72%、55%,手术+放疗患者为97%、95%、75%(对数秩检验p值=0.0026)。未接受早期辅助放疗的手术患者1年、2年和5年的PFS分别为64%、49%和27%,而手术+早期辅助放疗患者为81%、73%和59%(对数秩检验p值=0.0026)。未接受早期外照射放疗(EBRT)的手术患者1年、2年和5年的局部失败累积发生率分别为18.7%、35.0%和52.9%,而手术联合早期EBRT患者为4.2%、13.3%和20.0%(p值=0.02)。辅助放疗可提高AM患者的OS。早期辅助放疗可提高PFS,这可能是由于早期辅助EBRT能改善局部控制。